CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Almirall SA Company Snapshot
Almirall SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Almirall SA with three other pharmaceutical manufacturers in Europe: Guerbet SA of France (2018 sales of 789.60 million Euro [US$873.45 million] of which 44% was X-rays), Swedish Orphan Biovitrum AB (publ) of Sweden (9.14 billion Swedish Kronor [US$949.26 million] of which 100% was Sales of Pharmaceuticals), and BTG Plc which is based in the United Kingdom (£620.50 million [US$797.56 million] of which 39% was Interventional Medicine).

Sales Analysis. Almirall SA reported sales of 756.93 million Euro (US$837.31 million) for the year ending December of 2018. This represents an increase of 18.4% versus 2017, when the company's sales were 639.38 million Euro. Despite this increase, sales are still slightly below the level achieved in 2016, when Almirall SA reported sales of 764.36 million Euro. The sales level in 2018 was fairly close to the level five years ago: in 2013, Almirall SA had sales of 692.89 million Euro. Sales of Licenses saw an increase that was more than double the company's growth rate: sales were up 38.5% in 2018, from 79.83 million Euro to 110.59 million Euro. Almirall SA also saw significant increases in sales in Dermatology (up 32.9% to 109.88 million Euro) . Not all segments of Almirall SA experienced an increase in sales in 2018: sales of Corporate fell 0.1% to 25.93 million Euro. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Almirall SA
  Stock Performance Chart for Almirall SA
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 17.33
(Figures in Euro)
1 Week 2.1%   13 Weeks 9.2%  
4 Weeks 3.2%   52 Weeks 2.4%  
 
Almirall SA Key Data:
  Ticker: ALM Country: Spain
  Exchanges: BCN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 756,934,000
(Year Ending Jan 2019).
Employees: 1,791
  Currency: Euro Market Cap: 3,025,035,031
  Fiscal Yr Ends: December Shares Outstanding: 174,554,820
  Share Type: Accion Closely Held Shares: 117,261,219
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.